申请人:Aventis Pharmaceuticals Inc.
公开号:US07226921B2
公开(公告)日:2007-06-05
The present invention relates to novel selective cathepsin S inhibitors, the pharmaceutically acceptable salts and N-oxides thereof, their uses as therapeutic agents and the methods of their making.
本发明涉及新型选择性卡特普西林S抑制剂、其药学上可接受的盐和N-氧化物、它们作为治疗剂的用途以及它们的制备方法。